Results 221 to 230 of about 484,088 (306)

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study

open access: yesExploration, EarlyView.
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He   +16 more
wiley   +1 more source

Ribosomes: from conserved origin to functional/medical mobility and heterogeneity. [PDF]

open access: yesPhilos Trans R Soc Lond B Biol Sci
Rivalta A   +12 more
europepmc   +1 more source

Built differently or defective: can RNA exosomopathies cause ribosome heterogeneity? [PDF]

open access: yesPhilos Trans R Soc Lond B Biol Sci
Bressman ZJ, Corbett AH, Ghalei H.
europepmc   +1 more source

Structural insight into the novel Thermus thermophilus SPOUT methyltransferase RlmR catalysing Um2552 formation in the 23S rRNA A-loop: a case of convergent evolution. [PDF]

open access: yesNucleic Acids Res
Tanouti Y   +10 more
europepmc   +1 more source

The prognostic potential of RNA in stage II colon cancer: Insights from a screened multicenter population‐based cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Patients with stage II colon cancer exhibit considerable variation in prognosis. Consequently, decisions regarding the necessity of adjuvant chemotherapy in this population often rely on imperfect high‐risk criteria. Here, the authors developed a novel RNA‐based risk score, using NanoString nCounter technology, to stratify recurrence risk ...
Ulrik Korsgaard   +8 more
wiley   +1 more source

Nucleolar origins: challenging perspectives on evolution and function. [PDF]

open access: yesOpen Biol
Muñoz-Velasco I   +2 more
europepmc   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy